Assessment of pregestational insulin resistance as a risk factor of preeclampsia

Gynecologic and Obstetric Investigation

Volumn 77, Issue 2, 2014, Pages 111-116

  Valdés, Enrique ^a   Sepúlveda Martínez, Álvaro ^a   Manukián, Bárbara ^a   Parra Cordero, Mauro ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Doppler sonography; Hypothyroidism; Insulin resistance; Preeclampsia; Pregnancy

Indexed keywords

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTHYROIDISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREECLAMPSIA; PREGESTATIONAL INSULIN RESISTANCE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SECOND TRIMESTER PREGNANCY; UTERINE ARTERY; ANTHROPOMETRIC PARAMETERS; DISEASE ASSOCIATION; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HEMODYNAMIC PARAMETERS; HIGH RISK PREGNANCY; PREGNANT WOMAN; RISK ASSESSMENT; AGE; CHRONIC DISEASE; DIABETES, GESTATIONAL; ECHOGRAPHY; FETUS ECHOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZATION;

ADULT; AGE FACTORS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIABETES, GESTATIONAL; FEMALE; HUMANS; HYPERTENSION; HYPOTHYROIDISM; INSULIN RESISTANCE; PRE-ECLAMPSIA; PREGNANCY; RANDOM ALLOCATION; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 84896314611     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000357944     Document Type: Article

References (37)

1. Khong TY, De Wolf F, Robertson WB, Brosens I: Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small for gestational age infants. Br J Obstet Gynaecol 1986; 93: 1049-1059.
2. Roberts JM, Redman CWG: Pre-eclampsia: More than pregnancy induced hypertension. Lancet 1993; 341: 1447-1454.
3. Campbell S, Pearce JM, Hackett G, Cohen-Overbeek T, Hernandez C: Qualitative assessment of uteroplacental blood flow: Early screening test for high-risk pregnancies. Obstet Gynecol 1986; 68: 649-653.
4. Sibai BM: Prevention of preeclampsia: A big disappointment. Am J Obstet Gynecol 1998; 179: 1275-1278.
5. Arngrimsson R, Bjornsson S, Geirsson RT, Bjornsson H, Walker JJ, Snaedal G: Genetic and familial predisposition to eclampsia and preeclampsia in a defined population. Br J Obstet Gynecol 1990; 97: 762-769.
6. Robillard Py, Hulsey TC, Perianin J, Janky E, Miri EH, Papiernik E: Association of pregnancy induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344: 973-975.
7. Redman CW, Saks, GP, Sargent IL: Preeclampsia and excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol 1999; 180: 499-506.
8. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides K: Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011; 31: 66-74.
9. Timar O, Sestier F, Levy E: Metabolic syndrome X: A review. Can J Cardiol 2000; 16: 779-789.
10. Prado J, Ortiz JA, Lopez JL: Insulinoresistencia en la mujer. Rev Chil Obstet Ginec 2000; 66: 454-458.
11. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 16: 356-359.
12. Adams J, Polson DW, Franks S: Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 1986; 293: 355-359.
13. Adam PA, Teramo K, Raiha N, Gitlin D, Schwartz R: Human fetal insulin metabolism early in gestation. Response to acute elevation of the fetal glucose concentration and placental transfer of human insulin-I-131. Diabetes 1969; 18: 409-416.
14. Milner RD, Ashworth MA, Barson AJ: Insulin release from human foetal pancreas in response to glucose, leucine and arginine. J Endocrinol 1972; 52: 497-505.
15. Gillmer MD, Beard RW, Brooke FM, Oakley NW: Carbohydrate metabolism in pregnancy. I. Diurnal plasma glucose profile in normal and diabetic women. Br Med J 1975; 3: 399-402.
16. Ciaraldi TP, Kettel M, El-Roeiy A, et al: Mechanisms of cellular insulin resistance in human pregnancy. Am J Obstet Gynecol 1994; 170: 635-641.
17. Valdes ER, Lattes KA, Munoz HS, Barja PY, Papapietro KV: First-Trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction. Gynecol Obstet Invest 2011; 72: 152-156.
18. Solomon CG, Seely EW: Hypertension in pregnancy: A manifestation of the insulin resistance syndrome? Hypertension 2001; 37: 232-239.
19. Wolf M, Sandler L, Munoz K, Hsu K, Ecker JL, Thadhani R: First trimester insulin resistance and subsequent preeclampsia: A prospective study. J Clin Endocrinol Metab 2002; 87: 1563-1568.
20. Spencer K, Yu CK, Rembouskos G, Binda R, Nicolaides KH: First trimester sex hormonebinding globulin and subsequent preeclampsia or other adverse pregnancy outcomes. Hypertens Pregnancy 2005; 24: 303-311.
21. Wolf M, Sandler L, Jimenez-Kimble R, Shah A, Ecker J, Thadhani R: Insulin resistance but not inflammation is associated with gestational hypertension. Hypertension 2002; 40: 886-891.
22. Yu CK, Papageorghiou AT, Binda R, Spencer K, Nicolaides KH: Second-Trimester sex hormone-binding globulin and subsequent development of pre-eclampsia. J Matern Fetal Neonatal Med 2004; 16: 158-162.
23. Hauth J, Clifton R, Roberts J, Myatt L, Spong C, Leveno K, et al: Maternal insulin resistance and preeclampsia. Am J Obstet Gynecol 2011; 204: 327e1-327e6.
24. Alvarez JA, Bush NC, Hunter GR, Brock DW, Gower BA: Ethnicity and weight status affect the accuracy of proxy indices of insulin sensitivity. Obesity (Silver Spring) 2008; 16: 2739-2744.
25. Catalano PM: Obesity and pregnancy the propagation of a vicious cycle? J Clin Endocrinol Metab 2003: 88: 3505-3506.
26. Catalano PM, Ehrenberg HM: The short and long term implications of maternal obesity on the mother and her offspring. Br J Obstet Gynaecol 2006; 113: 1126-1133.
27. Catalano PM, Tyzbir ED, Roman NM, Amini SB, Sims EA: Longitudinal changes in insulin release and insulin resistance in non-obese pregnant women. Am J Obstet Gynecol 1991; 165: 1667-1672.
28. Papageorghious AT, Yu CK, Nicolaides KH: The role of uterine artery Doppler in predicting adverse pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 2004; 18: 383-396.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
30. American College of Endocrinology Position Statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237-252.
31. Brown MA, Lindheimer MD, de Swiet M, van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:ix-xiv.
32. Barton JR, Sibai BM: Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112: 359-372.
33. Buchanan T, Xiang AH: Gestational diabetes mellitus. J Clin Invest 2005; 115: 485-491.
34. Catalano P: Obesity, insulin resistance and pregnancy outcome. Reproduction 2010; 140: 365-371.
35. Steegers E, von Dadelszen P, Duvekot J, Pijnenborg R: Pre-eclampsia. Lancet 2010; 376: 631-644.
36. Dittrich R, Beckmann M, Oppelt P, Hoffmann I, Lotz L, Kuwert T, Mueller A: Thyroid hormone receptors and reproduction. J Reprod Immunol 2011; 90: 58-66.
37. Ramazan Gen, Akbay E, Sezer K: Insulin resistance and cardiovascular risk factors in patients with mild and severe subclinical hypothyroidism. Endocrinologist 2010; 20: 128-130.